Clinically based evidence of drug–herb interactions: a systematic review

Bibliography

• Boon HS, Olatunde F, Zick SM. Trends in complementary/alternative medicine use by breast cancer survivors: comparing survey data from 1998 and 2005. BMC women's health 2007;7:4
   PubMedGoogle Scholar
• Reid I. Baseline Natural Health Products Survey among Consumers. Final Report: Health Canada; 2005 March 2005
   Google Scholar
• Barnes P, Bloom B. Complementary and Alternative Medicine Use Among Adults and Children: United States, 2007: Centre for Disease Control and Prevention December 10, 2008
   Google Scholar
• Xin HW, Wu XC, Li Q, Effects of Schisandra sphenanthera extract on the pharmacokinetics of tacrolimus in healthy volunteers. Br J Clin Pharmacol 2007;64(4):469-75
   PubMed Web of Science ®Google Scholar
• Tanaka E, Hisawa S. Clinically significant pharmacokinetic drug interactions with psychoactive drugs: antidepressants and antipsychotics and the cytochrome P450 system. J Clin Pharmacy ther 1999;24(1):7-16
   PubMed Web of Science ®Google Scholar
• Bailey DG, Malcolm J, Arnold O, Spence JD. Grapefruit juice-drug interactions. Br J Clin Pharmacol 1998;46(2):101-10
   PubMed Web of Science ®Google Scholar
• Zhou SF, Lai X. An update on clinical drug interactions with the herbal antidepressant St. John's wort. Current drug metabolism 2008;9(5):394-409
   PubMed Web of Science ®Google Scholar
• Mills S, Bone K. Principles and practice of phytotherapy: modern herbal medicine. Edinburgh; New York: Churchill Livingstone; 2000
   Google Scholar
• Boon H, Smith M. 55 Most Common Medicinal Herbs. Toronto: Robert Rose; 2009
   Google Scholar
• Cavaliere C, Rea P, Blumenthal M. Herbal Supplement Sales in United States Show Growth in All Channels. HerbalGram; May-Jul 2008;(78): 60-3, 4p, 5 charts 2008 May-Jul 2008(78):60-3
   Google Scholar
• Gurley B, Hubbard MA, Williams DK, Assessing the clinical significance of botanical supplementation on human cytochrome P450 3A activity: comparison of a milk thistle and black cohosh product to rifampin and clarithromycin. J Clin Pharmacol 2006;46(2):201-13
   PubMed Web of Science ®Google Scholar
• Gurley BJ, Barone GW, Williams DK, Effect of milk thistle (Silybum marianum) and black cohosh (Cimicifuga racemosa) supplementation on digoxin pharmacokinetics in humans. Drug Metab Dispos 2006;34(1):69-74
   PubMed Web of Science ®Google Scholar
• Gurley BJ, Gardner SF, Hubbard MA, In vivo effects of goldenseal, kava kava, black cohosh, and valerian on human cytochrome P450 1A2, 2D6, 2E1, and 3A4/5 phenotypes. Clin Pharmacol Ther 2005;77(5):415-26
   PubMed Web of Science ®Google Scholar
• Gurley BJ, Swain A, Hubbard MA, Clinical assessment of CYP2D6-mediated herb-drug interactions in humans: effects of milk thistle, black cohosh, goldenseal, kava kava, St. John's wort, and Echinacea. Molecular nutrition & food research 2008;52(7):755-63
   PubMed Web of Science ®Google Scholar
• Piscitelli SC, Burstein AH, Welden N. The effect of garlic supplements on the pharmacokinetics of saquinavir. Clin Infect Dis 2002;34(2):234-8
   PubMed Web of Science ®Google Scholar
• Gwilt PR, Lear CL, Tempero MA, The effect of garlic extract on human metabolism of acetaminophen. Cancer Epidemiol Biomarkers Prev 1994;3(2):155-60
   PubMed Web of Science ®Google Scholar
• Gallicano K, Foster B, Choudhri S. Effect of short-term administration of garlic supplements on single-dose ritonavir pharmacokinetics in healthy volunteers. Br J Clin Pharmacol 2003;55(2):199-202
   PubMed Web of Science ®Google Scholar
• Abdul M, Jiang X, Williams K, Pharmacodynamic interaction of warfarin with cranberry but not with garlic in healthy subjects. Br J Pharmacol 2008;154:1691-700
   PubMed Web of Science ®Google Scholar
• Markowitz JS, Devane CL, Chavin KD. Effects of garlic (Allium sativum L.) supplementation on cytochrome P450 2D6 and 3A4 activity in healthy volunteers. Clin Pharmacol Ther 2003;74(2):170-7
   PubMed Web of Science ®Google Scholar
• Gurley BJ, Gardner SF, Hubbard MA, Clinical assessment of effects of botanical supplementation on cytochrome P450 phenotypes in the elderly: St John's wort, garlic oil, Panax ginseng and Ginkgo biloba. Drugs Aging 2005;22(6):525-39
   PubMed Web of Science ®Google Scholar
• Donovan JL, Chavin KD, Devane CL, Green tea (Camellia sinensis) extract does not alter cytochrome p450 3A4 or 2D6 activity in healthy volunteers. Drug Metab Dispos 2004;32(9):906-8
   PubMed Web of Science ®Google Scholar
• Chow HH, Hakim IA, Vining DR, Effects of repeated green tea catechin administration on human cytochrome P450 activity. Cancer Epidemiol Biomarkers Prev 2006;15(12):2473-6
   PubMed Web of Science ®Google Scholar
• Engels FK, de Jong FA, Sparreboom A, Medicinal cannabis does not influence the clinical pharmacokinetics of irinotecan and docetaxel. Oncologist 2007;12(3):291-300
   PubMed Web of Science ®Google Scholar
• Citrus aurantium, Professional monograph. Available from: www.naturalstandards.com [cited 11 February 2009]
   Google Scholar
• Gurley BJ, Gardner SF, Hubbard MA, In vivo assessment of botanical supplementation on human cytochrome P450 phenotypes: Citrus aurantium, Echinacea purpurea, milk thistle, and saw palmetto. Clin Pharmacol Ther 2004;76(5):428-40
   PubMed Web of Science ®Google Scholar
• Tankanow R, Tamer HR, Streetman DS, Interaction study between digoxin and a preparation of hawthorn (Crataegus oxyacantha). J Clin Pharmacol 2003;43(6):637-42
   PubMed Web of Science ®Google Scholar
• Curcuma longa, Professional monograph. Available from: www.naturalstandards.com [cited 2 April 2009]
   Google Scholar
• Juan H, Terhaag B, Cong Z, Unexpected effect of concomitantly administered curcumin on the pharmacokinetics of talinolol in healthy Chinese volunteers. Eur J Clin Pharmacol 2007;63(7):663-8
   PubMed Web of Science ®Google Scholar
• Gorski JC, Huang SM, Pinto A, The effect of echinacea (Echinacea purpurea root) on cytochrome P450 activity in vivo. Clin Pharmacol Ther 2004;75(1):89-100
   PubMed Web of Science ®Google Scholar
• Gurley BJ, Swain A, Williams DK, Gauging the clinical significance of P-glycoprotein-mediated herb-drug interactions: comparative effects of St. John's wort, Echinacea, clarithromycin, and rifampin on digoxin pharmacokinetics. Molecular nutrition & food research 2008;52(7):772-9
   PubMed Web of Science ®Google Scholar
• Donovan JL, DeVane CL, Chavin KD, Siberian ginseng (Eleutheroccus senticosus) effects on CYP2D6 and CYP3A4 activity in normal volunteers. Drug Metab Dispos 2003;31(5):519-22
   PubMed Web of Science ®Google Scholar
• Smith M, Lin KM, Zheng YP. An open trial of nifedipine-herb interactions: nifedipine with St. John's wort, ginseng, or Gingko biloba. Clin Pharmacol Ther 2001;69:86
   Google Scholar
• Aruna D, Naidu MU. Pharmacodynamic interaction studies of Ginkgo biloba with cilostazol and clopidogrel in healthy human subjects. Br J Clin Pharmacol 2007;63(3):333-8
   PubMed Web of Science ®Google Scholar
• Fan L, Mao XQ, Tao GY, Effect of Schisandra chinensis extract and Ginkgo biloba extract on the pharmacokinetics of talinolol in healthy volunteers. Xenobiotica; the fate of foreign compounds in biological systems 2009;39(3):249-54
   PubMed Web of Science ®Google Scholar
• Gardner CD, Zehnder JL, Rigby AJ, Effect of Ginkgo biloba (EGb 761) and aspirin on platelet aggregation and platelet function analysis among older adults at risk of cardiovascular disease: a randomized clinical trial. Blood Coagul Fibrinolysis 2007;18(8):787-93
   PubMed Web of Science ®Google Scholar
• Jiang X, Williams KM, Liauw WS, Effect of ginkgo and ginger on the pharmacokinetics and pharmacodynamics of warfarin in healthy subjects. Br J Clin Pharmacol 2005;59(4):425-32
   PubMed Web of Science ®Google Scholar
• Kudolo GB, Wang W, Javors M, Blodgett J. The effect of the ingestion of Ginkgo biloba extract (EGb 761) on the pharmacokinetics of metformin in non-diabetic and type 2 diabetic subjects–a double blind placebo-controlled, crossover study. Clinical nutrition (Edinburgh, Scotland) 2006;25(4):606-16
   PubMed Web of Science ®Google Scholar
• Markowitz JS, Donovan JL, Lindsay DeVane C, Multiple-dose administration of Ginkgo biloba did not affect cytochrome P-450 2D6 or 3A4 activity in normal volunteers. J Clin Psychopharmacol 2003;23(6):576-81
   PubMed Web of Science ®Google Scholar
• Mauro VF, Mauro LS, Kleshinski JF, Impact of ginkgo biloba on the pharmacokinetics of digoxin. Am J Ther 2003;10(4):247-51
   PubMedGoogle Scholar
• Robertson SM, Davey RT, Voell J, Effect of Ginkgo biloba extract on lopinavir, midazolam and fexofenadine pharmacokinetics in healthy subjects. Curr med Res Opin 2008;24(2):591-9
   PubMed Web of Science ®Google Scholar
• Uchida S, Yamada H, Li XD, Effects of Ginkgo biloba extract on pharmacokinetics and pharmacodynamics of tolbutamide and midazolam in healthy volunteers. J Clin Pharmacol 2006;46(11):1290-8
   PubMed Web of Science ®Google Scholar
• Wolf HR. Does Ginkgo biloba special extract EGb 761 provide additional effects on coagulation and bleeding when added to acetylsalicylic acid 500 mg daily? Drugs R D 2006;7(3):163-72
   PubMedGoogle Scholar
• Yin OQ, Tomlinson B, Waye MM, Pharmacogenetics and herb-drug interactions: experience with Ginkgo biloba and omeprazole. Pharmacogenetics 2004;14(12):841-50
   PubMedGoogle Scholar
• Yoshioka M, Ohnishi N, Koishi T, Studies on interactions between functional foods or dietary supplements and medicines. IV. Effects of ginkgo biloba leaf extract on the pharmacokinetics and pharmacodynamics of nifedipine in healthy volunteers. Biol Pharm Bull 2004;27(12):2006-9
   PubMed Web of Science ®Google Scholar
• Chatterjee SS, Doelman CJ, Noldner M, Influence of the Ginkgo extract EGb 761 on rat liver cytochrome P450 and steroid metabolism and excretion in rats and man. J Pharm Pharmacol 2005;57(5):641-50
   PubMed Web of Science ®Google Scholar
• Markowitz J, DeVane C, Donovan J, Resch S. An Assessment of CYP2D6 inhibitory effects of Ginkgo biloba in normal volunteers. Int J Neuropsychopharmacol 2002;5:s192
   Google Scholar
• Mohutsky MA, Anderson GD, Miller JW, Elmer GW. Ginkgo biloba: evaluation of CYP2C9 drug interactions in vitro and in vivo. Am J Ther 2006;13(1):24-31
   PubMedGoogle Scholar
• Gurley BJ, Swain A, Barone GW, Effect of goldenseal (Hydrastis canadensis) and kava kava (Piper methysticum) supplementation on digoxin pharmacokinetics in humans. Drug Metab Dispos 2007;35(2):240-5
   PubMed Web of Science ®Google Scholar
• Gurley BJ, Swain A, Hubbard MA, Supplementation with goldenseal (Hydrastis canadensis), but not kava kava (Piper methysticum), inhibits human CYP3A activity in vivo. Clin Pharmacol Ther 2008;83(1):61-9
   PubMed Web of Science ®Google Scholar
• Sandhu RS, Prescilla RP, Simonelli TM, Edwards DJ. Influence of goldenseal root on the pharmacokinetics of indinavir. J Clin Pharmacol 2003;43(11):1283-8
   PubMed Web of Science ®Google Scholar
• Dresser GK, Wacher V, Wong S, Evaluation of peppermint oil and ascorbyl palmitate as inhibitors of cytochrome P4503A4 activity in vitro and in vivo. Clin Pharmacol Ther 2002;72(3):247-55
   PubMed Web of Science ®Google Scholar
• Jiang X, Williams KM, Liauw WS, Effect of St John's wort and ginseng on the pharmacokinetics and pharmacodynamics of warfarin in healthy subjects. Br J Clin Pharmacol 2004;57(5):592-9
   PubMed Web of Science ®Google Scholar
• Andrade AS, Hendrix C, Parsons TL, Pharmacokinetic and metabolic effects of American ginseng (Panax quinquefolius) in healthy volunteers receiving the HIV protease inhibitor indinavir. BMC Complement Altern Med 2008;8:50
   PubMed Web of Science ®Google Scholar
• Lee LS, Wise SD, Chan C, Possible differential induction of phase 2 enzyme and antioxidant pathways by american ginseng, Panax quinquefolius. J Clin Pharmacol 2008;48(5):599-609
   PubMed Web of Science ®Google Scholar
• Yuan CS, Wei G, Dey L, Brief communication: American ginseng reduces warfarin's effect in healthy patients: a randomized, controlled Trial. Ann Intern Med 2004;141(1):23-7
   PubMed Web of Science ®Google Scholar
• Piper methysticum, Professional monograph. Available from: www.naturalstandards.com [cited 11 February 2009]
   Google Scholar
• Schisandra sphenanthera, Professional Mongraph. Available from: www.naturalstandards.com [cited 11 February 2009]
   Google Scholar
• Gerber GS. Saw palmetto for the treatment of men with lower urinary tract symptoms. J urol 2000;163(5):1408-12
   PubMed Web of Science ®Google Scholar
• Markowitz JS, Donovan JL, Devane CL, Multiple doses of saw palmetto (Serenoa repens) did not alter cytochrome P450 2D6 and 3A4 activity in normal volunteers. Clin Pharmacol Ther 2003;74(6):536-42
   PubMed Web of Science ®Google Scholar
• DiCenzo R, Shelton M, Jordan K, Coadministration of milk thistle and indinavir in healthy subjects. Pharmacotherapy 2003;23(7):866-70
   PubMed Web of Science ®Google Scholar
• Fuhr U, Beckmann-Knopp S, Jetter A, The effect of silymarin on oral nifedipine pharmacokinetics. Planta medica 2007;73(14):1429-35
   PubMed Web of Science ®Google Scholar
• Mills E, Wilson K, Clarke M, Milk thistle and indinavir: a randomized controlled pharmacokinetics study and meta-analysis. Eur J Clin Pharmacol 2005;61(1):1-7
   PubMed Web of Science ®Google Scholar
• Piscitelli SC, Formentini E, Burstein AH, Effect of milk thistle on the pharmacokinetics of indinavir in healthy volunteers. Pharmacotherapy 2002;22(5):551-6
   PubMed Web of Science ®Google Scholar
• van Erp NP, Baker SD, Zhao M, Effect of milk thistle (Silybum marianum) on the pharmacokinetics of irinotecan. Clin Cancer Res. 2005 11(21):7800-6
   PubMed Web of Science ®Google Scholar
• Deng JW, Shon JH, Shin HJ, Effect of silymarin supplement on the pharmacokinetics of rosuvastatin. Pharm Res 2008 25(8):1807-14
   PubMed Web of Science ®Google Scholar
• Leber HW, Knauff S. Influence of silymarin on drug metabolizing enzymes in rat and man. Arzneimittel-Forschung 1976;26(8):1603-5
   PubMed Web of Science ®Google Scholar
• Rajnarayana K, Reddy MS, Vidyasagar J, Krishna DR. Study on the influence of silymarin pretreatment on metabolism and disposition of metronidazole. Arzneimittel-Forschung 2004;54(2):109-13
   PubMed Web of Science ®Google Scholar
• Rao BN, Srinivas M, Kumar YS, Rao YM. Effect of silymarin on the oral bioavailability of ranitidine in healthy human volunteers. Drug Metabol Drug Interact 2007;22(2-3):175-85
   PubMedGoogle Scholar
• Ansell J, McDonough M, Harmatz J, Greenblatt DJ. A randomized double-blind trial of the interaction between cranberry juice and warfarin. J Thromb Thrombolysis 2007;25:112
   Web of Science ®Google Scholar
• Greenblatt DJ, von Moltke LL, Perloff ES, Interaction of flurbiprofen with cranberry juice, grape juice, tea, and fluconazole: in vitro and clinical studies. Clin Pharmacol Ther 2006;79(1):125-33
   PubMed Web of Science ®Google Scholar
• Grenier J, Fradette C, Morelli G, Pomelo juice, but not cranberry juice, affects the pharmacokinetics of cyclosporine in humans. Clin Pharmacol Ther 2006;79(3):255-62
   PubMed Web of Science ®Google Scholar
• Li Z, Seeram NP, Carpenter CL, Cranberry does not affect prothrombin time in male subjects on warfarin. Journal of the American Dietetic Association 2006;106(12):2057-61
   PubMed Web of Science ®Google Scholar
• Lilja JJ, Backman JT, Neuvonen PJ. Effects of daily ingestion of cranberry juice on the pharmacokinetics of warfarin, tizanidine, and midazolam--probes of CYP2C9, CYP1A2, and CYP3A4. Clin Pharmacol Ther 2007;81(6):833-9
   PubMed Web of Science ®Google Scholar
• Donovan JL, DeVane CL, Chavin KD, Multiple night-time doses of valerian (Valeriana officinalis) had minimal effects on CYP3A4 activity and no effect on CYP2D6 activity in healthy volunteers. Drug Metab Dispos 2004;32(12):1333-6
   PubMed Web of Science ®Google Scholar
• Zingiber officinale, Professional monograph. Available from: www.naturalstandards.com [cited 11 February 2009]
   Google Scholar
• Chang GW, Kam PC. The physiological and pharmacological roles of cytochrome P450 isoenzymes. Anaesthesia 1999;54(1):42-50
   PubMed Web of Science ®Google Scholar
• Gonzalez FJ, Gelboin HV. Role of human cytochromes P450 in the metabolic activation of chemical carcinogens and toxins. Drug Metab Rev 1994;26(1-2):165-83
   PubMed Web of Science ®Google Scholar
• Shapiro LE, Shear NH. Drug interactions: Proteins, pumps, and P-450s. Journal of the American Academy of Dermatology 2002;47(4):467-84; quiz 85-8
   PubMed Web of Science ®Google Scholar
• Kalra BS. Cytochrome P450 enzyme isoforms and their therapeutic implications: an update. Indian journal of medical sciences 2007;61(2):102-16
   PubMedGoogle Scholar
• Omari AA, Murry DJ. Pharmacogenetics of the Cytochrome P450 Enzyme System: Review of Current Knowledge. J Pharm Pract 2007;20:206-8
   Google Scholar
• Pirmohamed M, Park BK. Cytochrome P450 enzyme polymorphisms and adverse drug reactions. Toxicology 2003;192(1):23-32
   PubMed Web of Science ®Google Scholar
• Peng WX, Li HD, Zhou HH. Effect of daidzein on CYP1A2 activity and pharmacokinetics of theophylline in healthy volunteers. Eur J Clin Pharmacol 2003;59(3):237-41
   PubMed Web of Science ®Google Scholar
• Chen MF, Shimada F, Kato H, Effect of glycyrrhizin on the pharmacokinetics of prednisolone following low dosage of prednisolone hemisuccinate. Endocrinologia japonica 1990;37(3):331-41
   PubMedGoogle Scholar
• Chen MF, Shimada F, Kato H, Effect of oral administration of glycyrrhizin on the pharmacokinetics of prednisolone. Endocrinologia japonica 1991;38(2):167-74
   PubMedGoogle Scholar
• Izzo AA. Herb-drug interactions: an overview of the clinical evidence. Fundam Clin Pharm 2005;19(1):1-16
   PubMed Web of Science ®Google Scholar
• Ginkgo biloba, Professional monograph. Available from: www.naturalstandards.com [cited 11 February 2009]
   Google Scholar
• Silybum maranium, Professional monograph. Available from: www.naturalstandards.com [cited 11 February 2009]
   Google Scholar
• Abou-Donia MB, El-Masry EM, Abdel-Rahman AA, Splenda alters gut microflora and increases intestinal p-glycoprotein and cytochrome p-450 in male rats. Journal of toxicology and environmental health 2008;71(21):1415-29
   Web of Science ®Google Scholar
• Pattanaik S, Hota D, Prabhakar S, Effect of piperine on the steady-state pharmacokinetics of phenytoin in patients with epilepsy. Phytother Res 2006;20(8):683-6
   PubMed Web of Science ®Google Scholar
• Mei Y, Qian F, Wei D, Liu J. Reversal of cancer multidrug resistance by green tea polyphenols. J Pharm. Pharmacol 2004;56(10):1307-14
   Web of Science ®Google Scholar
• Zhang Q, Wei D, Liu J. In vivo reversal of doxorubicin resistance by (-)-epigallocatechin gallate in a solid human carcinoma xenograft. Cancer letters 2004;208(2):179-86
   PubMed Web of Science ®Google Scholar
• Hydrastis canadensis, Professional monograph. Available from: www.naturalstandards.com [cited 11 February 2009]
   Google Scholar